PR Newswire: news distribution, targeting and monitoring

Top Stocks on the Move: VuMee Inc., AMR Corp., InVivo Therapeutics Holdings Corp., and Advaxis Inc.

Share with Twitter Share with LinkedIn

NEW YORK, January 10, 2013 /PRNewswire/ -- provides investors with quality research and analysis on U.S. equities on the move and today issues a report on: VuMee Inc. (OTCBB: VUME), AMR Corp. (OTCBB: AAMRQ), InVivo Therapeutics Holdings Corp. (OTCBB: NVIV), and Advaxis Inc. (OTCBB: ADXS)

VuMee Inc. (OTCBB: VUME) continues to increase the monetization of their video sharing content from both the desktop and mobile platforms. VuMee has entered into agreements with, ValueClick Media, and Casale Media to provide additional pre-roll and banner advertisements. The Company expects these agreements to greatly increase advertising revenue.

VuMee Inc. gained 135% on January 9th on a massive volume increase.

Read the entire press release issued by VuMee Inc. (OTCBB: VUME) here:

AMR Corp. (OTCBB: AAMRQ) rallied nearly 44% and traded about 15 times higher than the average 3 month volume on December 9th after a company lawyer said stockholders might get something back when the company emerges from bankruptcy protection. Companies often issue new stock after exiting bankruptcy, rendering the old shares worthless.

Read the entire press release issued by AMR Corp. (OTCBB: AAMRQ) here:

InVivo Therapeutics Inc. (OTCBB: NVIV) is finishing up presenting at the 5th Annual Biotech Showcase that took place in San Francisco from January 7-9. CEO, Frank Reynolds, participated in a panel titled "Spinal Cord Injury: Investment Opportunities and Challenges in an Area with Unmet Medical Needs." After the panel, Reynolds gave a corporate presentation on InVivo Therapeutics.

CEO, Frank Reynolds, seems to have impressed the crowd as InVivo Therapeutics has gained nearly 33% during the three day biotech showcase.

Read the entire press release issued by InVivo Therapeutics Inc. (OTCBB: NVIV) here:

Advaxis Inc. (OTCBB: ADXS) is another company seeing a pop after presenting at a conference. Advaxis presented at the 6th Annual One Med Forum on January 8th in San Francisco. Advaxis is working towards developing the next generation of immunotherapies for cancer and infectious diseases.

Advaxis Inc. gained 70% in two days after presenting at the conference.

Read the entire press release issued by Advaxis Inc. (OTCBB: ADXS) here:  

Sign up to receive detailed reports and stock picks at For real-time trade updates, follow our award winning hedge fund trader on Twitter @StockBrainiac. Premier Equity Reports also offers a FREE text message alert service to ensure that you receive all alerts. Simply text "reports" to 63566.

Premier Equity Reports is the U.S. leader in equity reports, offering quality reports to investors looking for the most undervalued companies in the market. Premier Equity Reports provides its subscribers with timely information and exclusive analysis on U.S. companies with substantial upside potential. Premier Equity Reports is the #1 free financial newsletter in the industry. Sign up now and see why thousands have joined already.

Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Premier Equity Reports is a wholly owned entity of Equities Awareness Group LLC. Equities Awareness Group LLC has not been compensated by any of the companies mentioned above. Please read our report and visit our website, for complete risks and disclosures.

Contact Information:
Equities Awareness Group LLC
Michael Perinotti

Third Party Publishing Provider: FNNewswire, a FN Media Group, LLC Company.

SOURCE Equities Awareness Group LLC

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos and customised feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn

Get content for your website

Enhance your website's or blog's content with PR Newswire's customised real-time news feeds.
Start today.



Contact PR Newswire

Send us an email at or call us at +44 (0)20 7454 5382



Become a PR Newswire client

Request more information about PR Newswire products & services or call us at +44 (0)20 7454 5382


Regulatory News Search
  1. Products & Services
  2. Knowledge Centre
  3. Browse News Releases
  4. Meet the Media
  5. Contact PR Newswire